• Company
• Company Roche and Drug Keytruda will lead industry in 5 yrs
• by Kim, Jin-Gu Aug 25, 2023 06:06am

• Product
• Hugel’s 'Licellvi Webinar' Successfully Completed
• by 어윤호 Aug 24, 2023 09:00am

• Opinion
• [Reporter's view] Hemophilia drug war of nerves
• by Kim, Jin-Gu Aug 24, 2023 05:46am

• Policy
• Verquvo will be listed for reimb at KRW 2,867 in KOR
• by Kim, Jung-Ju Aug 24, 2023 05:46am

• Policy
• Generics for Januvia are deleted from the reimbursement list
• by Lee, Tak-Sun Aug 24, 2023 05:46am

• Company
• Will the new NMOSD drug Enspryng be reimbursed in KOR?
• by Eo, Yun-Ho Aug 24, 2023 05:46am

• Policy
• Conflict rise over the need of the PE exemption system
• by Lee, Jeong-Hwan Aug 24, 2023 05:45am

• Company
• The report distorted the side effects of JW Pharma Hemlibra
• by Kim, Jin-Gu Aug 23, 2023 05:46am

• Policy
• 157 single and 82 combo Januvia generics reimbursed in KOR
• by Lee, Tak-Sun Aug 23, 2023 05:46am

• Policy
• 'No other country has a PE exemption system'
• by Lee, Jeong-Hwan Aug 23, 2023 05:46am